R
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NCM – Real vaqt narxi. Valyuta: USD
0.80
+0.00 (0.01%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.80
+0.00 (0.01%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Reviva Pharmaceuticals Holdings, Inc., biotexnologiya kompaniyasi, markaziy asab tizimi, nafas olish, yallig'lanish va kardiometabolik kasalliklar sohalarida qondirilmagan tibbiy ehtiyojlarga mo'ljallangan kasalliklar uchun yangi avlod dorilarni kashf etadi, ishlab chiqadi va tijoratlashtiradi. Kompaniyaning asosiy dori nomzodi shizofreniya, bipolyar buzuqlik, katta depressiv buzuqlik, diqqat etishmovchiligi/giperaktivlik buzuqligi, demensiya va Altsheymer kasalligining xulq-atvor va psixotik belgilari, shuningdek, Parkinson kasalligi bilan bog'liq psixoz kabi nevropsixiatrik ko'rsatmalar uchun brilaroxazin (RP5063)ni o'z ichiga oladi. Kompaniya shuningdek, o'pka arteriya gipertenziyasi va idiomatik o'pka fibrozisi kabi nafas olish ko'rsatmalari bo'yicha klinik rivojlanish bilan shug'ullanadi. Qo'shimcha ravishda, kompaniya psoriazni davolash uchun preklinik rivojlanish bosqichida; va depressiya va semirishni davolash uchun RP1208ni ishlab chiqmoqda. Kompaniya 2018 yilda tashkil etilgan va Kaliforniyaning Kuperino shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Laxminarayan Bhat Ph.D. | Founder, CEO, President & Director |
| Mr. Narayan Prabhu | CFO, Treasurer & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-15 | 8-K | rvph20260414_8k.htm |
| 2026-03-30 | 8-K | rvph20260313_8k.htm |
| 2026-03-19 | 8-K | rvph20260319_8k.htm |
| 2026-03-05 | 8-K | rvph20260227_8k.htm |
| 2026-01-23 | 8-K | rvph20260122_8k.htm |
| 2025-12-23 | 8-K | rvph20251216_8k.htm |
| 2025-12-05 | DEFA14A | rvph20251203_defa14a.htm |
| 2025-11-13 | 8-K | rvph20251103_8k.htm |
| 2025-11-13 | 10-Q | rvph20250930_10q.htm |
| 2025-11-04 | DEFA14A | rvph20251029_defa14a.htm |